Prof. Dr. Matthias Beckmann

Lehrstuhl für Geburtshilfe und Frauenheilkunde

Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix (2018) Jesinghaus M, Strehl J, Boxberg M, Bruehl F, Wenzel A, Konukiewitz B, Schlitter AM, et al. Journal article Whole-Body Electromyostimulation combined with personalized Nutritional Support improves the Body Composition of Patients with advanced Cancer (2018) Schink K, Herrmann HJ, Schwappacher R, Orlemann T, Meyer J, Waldmann E, Wullich B, et al. Conference contribution rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology (2018) Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching P, Beckmann M, Ekici AB, et al. Journal article Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial (2018) Schink K, Herrmann HJ, Schwappacher R, Meyer J, Orlemann T, Waldmann E, Wullich B, et al. Journal article TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes (2018) Erber R, Hartmann A, Beckmann M, Mackensen A, Kremer A, Reimann H, Hübner H, et al. Journal article Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer (2018) Gaß P, Lux MP, Rauh C, Hein A, Bani M, Fießler C, Hartmann A, et al. Journal article Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS) (2018) Gebrekidan M, Erber R, Hartmann A, Fasching P, Emons J, Beckmann M, Bräuer A Journal article The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer (2018) Brennan M, Gaß P, Häberle L, Wang D, Hartmann A, Lux MP, Beckmann M, et al. Journal article Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians (2018) Gaß P, Untch M, Mueller V, Moebus V, Thomssen C, Häberle L, Erber R, et al. Journal article Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria (2018) Hoyer J, Vasileiou G, Uebe S, Wunderle M, Kraus C, Fasching P, Thiel C, et al. Journal article